http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19022700

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 397
issn 1549-9634
issueIdentifier 2
pageRange 387-397
publicationName Nanomedicine : nanotechnology, biology, and medicine
startingPage 387
bibliographicCitation Wang X, Chen X, Yang X, Gao W, He B, Dai W, Zhang H, Wang X, Wang J, Zhang X, Dai Z, Zhang Q. A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine. 2016 Feb;12(2):387–97. doi: 10.1016/j.nano.2015.12.360.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc762a1020ec837a9837b9688907864
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1623caf47e55db9460bc34b1c05103de
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0a21f0f27e5c82d640d61dacd8b5d75
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d79599a0e9579a761eb1eff78921b96
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ae135bfc2200be12ff9608766b28bee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c537b3e815dcfcaa222ad79e270106f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5233-3734
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_390524a6bdb8badba8a1d4a4e4aac16a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_899a20745b80347046b9fee5d8c391b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0eb6543001599c7f023fa64a3232ef69
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_359692e1f827d13aa20adbe99093a3c0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7f9dca4eb60afbb5fdf3853ab48e742
date 201602
identifier https://pubmed.ncbi.nlm.nih.gov/26711969
https://doi.org/10.1016/j.nano.2015.12.360
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32817
https://portal.issn.org/resource/ISSN/1549-9634
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer
discusses http://id.nlm.nih.gov/mesh/M0220651
http://id.nlm.nih.gov/mesh/M0001348
http://id.nlm.nih.gov/mesh/M0539373
http://id.nlm.nih.gov/mesh/M0138075
http://id.nlm.nih.gov/mesh/M0028300
http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0012600
http://id.nlm.nih.gov/mesh/M0015279
http://id.nlm.nih.gov/mesh/M0017182
http://id.nlm.nih.gov/mesh/M0006823
http://id.nlm.nih.gov/mesh/M0021024
http://id.nlm.nih.gov/mesh/M0417713
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013629Q000008
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D009842Q000378
http://id.nlm.nih.gov/mesh/D057846Q000378
http://id.nlm.nih.gov/mesh/D008081Q000378
http://id.nlm.nih.gov/mesh/D004317Q000031
http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000903Q000627
http://id.nlm.nih.gov/mesh/D013629Q000627
http://id.nlm.nih.gov/mesh/D008081Q000737
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D000072200Q000378
http://id.nlm.nih.gov/mesh/D000903Q000008
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D004338
http://id.nlm.nih.gov/mesh/D018931Q000008
http://id.nlm.nih.gov/mesh/D009842Q000737
http://id.nlm.nih.gov/mesh/D011092Q000627
http://id.nlm.nih.gov/mesh/D057846Q000737
http://id.nlm.nih.gov/mesh/D051028Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018931Q000627
http://id.nlm.nih.gov/mesh/D011092Q000008
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D001940Q000473
http://id.nlm.nih.gov/mesh/D001940Q000378
http://id.nlm.nih.gov/mesh/D001940Q000187
http://id.nlm.nih.gov/mesh/D050997
http://id.nlm.nih.gov/mesh/D001943Q000473
http://id.nlm.nih.gov/mesh/D001943Q000378
http://id.nlm.nih.gov/mesh/D004317Q000627
http://id.nlm.nih.gov/mesh/D004317Q000008
http://id.nlm.nih.gov/mesh/D000072200Q000737
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f9bf303de3f0e3ae17c7ee05bc511639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c9cc67cee7fb3ffbf148f7861b880273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Total number of triples: 86.